Rosácea: factores asociados y presentación clínica en una población santandereana

Vista sencilla de ítem
dc.contributor.advisorCamacho López, Paul Anthony
dc.contributor.apolounabCamacho López, Paul Anthony [paul-anthony-camacho-lópez]
dc.contributor.authorRamírez Blanco, Natalia Milena
dc.contributor.authorMosquera Sánchez, Hernando
dc.contributor.cvlacCamacho López, Paul Anthony [0000323578]spa
dc.contributor.cvlacTello Hernández, Alejandro [0001009125]spa
dc.contributor.cvlacFrederick Velásquez, Gabriel [001624849]spa
dc.contributor.cvlacParra Castillo, María Margarita [0001611191]spa
dc.contributor.googlescholarCamacho López, Paul Anthony [u8d7_QAAAAJ&hl=es]spa
dc.contributor.googlescholarTello Hernández, Alejandro [puxZHKYAAAAJ]spa
dc.contributor.linkedinCamacho López, Paul Anthony [paulcamachomdepi]
dc.contributor.orcidCamacho López, Paul Anthony [0000-0002-6233-9582]spa
dc.contributor.orcidTello Hernández, Alejandro [0000-0001-5081-0720]spa
dc.contributor.orcidParra Castillo, María Margarita [0000-0002-2167-2207]spa
dc.contributor.otherTello Hernández, Alejandrospa
dc.contributor.otherFrederick Velásquez, Gabrielspa
dc.contributor.otherParra Castillo, María Margaritaspa
dc.contributor.researchgateCamacho López, Paul Anthony [Paul-Camacho-Lopez]spa
dc.contributor.researchgateTello Hernández, Alejandro [Alejandro_Tello2]spa
dc.contributor.scopusCamacho López, Paul Anthony [16047325700]spa
dc.contributor.scopusTello Hernández, Alejandro [6603664598]spa
dc.coverage.campusUNAB Campus Bucaramangaspa
dc.coverage.spatialSantander (Colombia)spa
dc.coverage.temporal2015spa
dc.date.accessioned2022-10-31T20:26:12Z
dc.date.available2022-10-31T20:26:12Z
dc.date.issued2015
dc.degree.nameEspecialista en Dermatologíaspa
dc.description.abstractLa rosácea es una enfermedad inflamatoria crónica de la piel que afecta casi exclusivamente la cara central (mejillas, mentón, nariz y frente central) y respeta la región perioral y periocular, caracterizada por exacerbaciones y remisiones. (1-3) Los datos epidemiológicos en la rosácea son escasos, con reportes de prevalencia de hasta el 20% en la población general. Algunos estudios reportan una prevalencia menor del 1% a más del 20%,(3) estos estudios han sido realizado en países Europeos (Alemania, Irlanda, Suecia, Estonia, Grecia) y en Estados Unidos. (4) La rosácea usualmente se diagnostica luego de la tercera década.(4) Se ha observado con mayor frecuencia en personas de piel clara, aunque también ha sido descrita en Asiáticos y Africoamericanos y ocurre tanto en hombres como en mujeres, siendo más común en mujeres, pero la presencia de rinofima es mayor en hombres. (5) Como factores de riesgo se han mencionado: componente genético, la infestación por demodex folliculorum, el sexo, edad y fototipo de piel. Se han descrito factores agravantes ó precipitantes entre los que se encuentran la radiación UV, calor, frío, comidas picantes y alcohol entre otras.spa
dc.description.abstractenglishRRosacea is a chronic inflammatory skin disease that almost exclusively affects the central face (cheeks, chin, nose and central forehead) and spares the perioral and periocular region, characterized by exacerbations and remissions. (1-3) Epidemiological data on rosacea are scarce, with prevalence reports of up to 20% in the general population. Some studies report a prevalence of less than 1% to more than 20%,(3) these studies have been carried out in European countries (Germany, Ireland, Sweden, Estonia, Greece) and in the United States. (4) Rosacea is usually diagnosed after the third decade.(4) It has been observed more frequently in fair-skinned people, although it has also been described in Asians and African-Americans and occurs in both men and women, being more common in women, but the presence of rhinophyma is greater in men. (5) As risk factors have been mentioned: genetic component, the Demodex folliculorum infestation, sex, age and skin phototype. Aggravating or precipitating factors have been described, including UV radiation, heat, cold, spicy foods and alcohol, among others.spa
dc.description.degreelevelEspecializaciónspa
dc.description.learningmodalityModalidad Presencialspa
dc.description.tableofcontentsINTRODUCCIÓN ........................................................................................ 3 1. Justificación............................................................................... 4 2. Marco teórico............................................................................... 5 3. Objetivos........................................................................................26 3.1 Objetivo General..................................................................... 26 3.2 Objetivos Específicos............................................................. 26 4. Metodología...................................................................................27 4.1 Tipo de estudio....................................................................... 27 4.2 Universo................................................................................... 27 4.3 Población.................................................................................27 4.4 Criterios de Inclusión............................................................. 27 4.5 Criterios de Exclusión............................................................ 27 4.6 Procedimientos....................................................................... 27 4.7 Variables.................................................................................. 28 4.7.1 Tabla de variables.....................................................28 4.8 Análisis....................................................................................36 5. Consideraciones Éticas............................................................. 37 6. Resultados....................................................................................38 7. Discusión..................................................................................... 40 8. Conclusiones................................................................................43 9. Bibliografía...................................................................................44 10. Anexos....................................................................................... 49 11. Tablas......................................................................................... 55spa
dc.format.mimetypeapplication/pdfspa
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga - UNABspa
dc.identifier.reponamereponame:Repositorio Institucional UNABspa
dc.identifier.repourlrepourl:https://repository.unab.edu.cospa
dc.identifier.urihttp://hdl.handle.net/20.500.12749/18274
dc.language.isospaspa
dc.publisher.facultyFacultad Ciencias de la Saludspa
dc.publisher.grantorUniversidad Autónoma de Bucaramanga UNABspa
dc.publisher.programEspecialización en Dermatologíaspa
dc.relation.referencesWilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol [Internet], 2002 Apr [cited 2014 Sep 9];46(4):584-7. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0190962202426977spa
dc.relation.referencesSteinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol [Internet], 2013 Dec [cited 2014 Jun 25];69(6 Suppl 1):S15-26. Available from: http://vwvw.ncbi.nlm.nih.gov/pubmed/24229632spa
dc.relation.referencesElewski BE, Draelos Z, Dréno B, Jansen T, Layton a, Picardo M. Rosacea - global diversity and optimized outeome: proposed international consensus from the Rosacea International Expert Group. J Eur Acad Dermatol Venereol [Internet], 2011 Feb [cited 2014 Jun 3];25(2): 188-200. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20586834spa
dc.relation.referencesEpidemiologic aspeets of rosacea. J Am Acad Dermatol. 2005;53(5):918- 9.spa
dc.relation.referencesFaad HEB. Diagnosis and Treatment of Rosacea: State of the Art. 2012;11(6):725-30.spa
dc.relation.referencesElewski BE, Draelos Z, Dréno B, Jansen T, Layton A, Picardo M. Rosacea - Global diversity and optimized outeome: Proposed international consensus from the Rosacea international expert group. J Eur Acad Dermatology Venereol. 2011;25:188-200.spa
dc.relation.referencesTan J, Berg M. Rosacea: current state of epidemiology. J Am Acad Dermatol [Internet]. Elsevier Inc; 2013 Dec [cited 2014 Jun 25];69(6 Suppl 1):S27-35. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24229634spa
dc.relation.referencesG L. Prevalence of skin diseases in a population; a census study from the Faroe Islands. Dan Med Bull 1964;11:1-7. Dan Med Bull. 1964;11:1-7.spa
dc.relation.referencesSchaefer I, Rustenbach SJ, Zimmer L, Augustin M. Prevalence of skin diseases in a cohort of 48,665 employees in Germany. Dermatology. 2008;217:169-72.spa
dc.relation.referencesAugustin M, Herberger K, Hintzen S, Heigel H, Franzke N, Scháfer I. Prevalence of skin lesions and need for treatment in a cohort of 90 880 workers. Br J Dermatol. 2011;165:865-73.spa
dc.relation.referencesBerg M, Liden S. An epidemiological study of rosacea. Acta Derm Venereol. 1989;69:419-23.spa
dc.relation.referencesKhaled A, Hammami H, Zeglaoui F, Tounsi J, Zermani R, Kamoun MR, et al. Rosacea: 244 Tunisian cases. Tunisie Medícale. 2010;88:597-601.spa
dc.relation.referencesLazaridou E, Fotiadou C, Ziakas NG, Giannopoulou C, Apalla Z, loannides D. Clinical and laboratory study of ocular rosacea ín northern Greece. J EurAcad Dermatology Venereol. 2011;25:1428-31.spa
dc.relation.referencesGhanem VC, Mehra N, Wong S, Mannis MJ. The prevalence of ocular signs ¡n acné rosacea: comparing patients from ophthalmology and dermatology clinics. Cornea. 2003;22:230-3.spa
dc.relation.referencesSpoendlin J, Voegel JJ, Jick SS, Meier CR. A study on the epidemiology of rosacea in the U.K. Br J Dermatol [Internet]. 2012 Sep [cíted 2014 Jun 25];167(3):598-605. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22564022spa
dc.relation.referencesCasas C, Paúl C, Lahfa M, Livideanu B, Lejeune O, Alvarez-Georges S, et al. Quantification of Demodex follículorum by PCR in rosacea and its relationship to skin innate immune activation. Exp Dermatol [Internet], 2012 Dec [cíted 2014 Jun 25];21(12):906-10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23171449spa
dc.relation.referencesJarmuda S, O’Reilly N, Zaba R, Jakubowicz O, Szkaradkiewicz A, Kavanagh K. Potential role of Demodex mites and bacteria in the induction of rosacea. Journal of Medical Microbiology. 2012. p. 1504-10.spa
dc.relation.referencesHolmes AD. Potential role of microorganisms in the pathogenesis of rosacea. J Am Acad Dermatol [Internet], Elsevier Inc; 2013 Dec [cíted 2014 Jun 2];69(6): 1025-32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24011460spa
dc.relation.referencesChauhan N, Ellis D a F. Rosacea: pathophysiology and management principies. Facial Plast Surg Clin North Am [Internet], 2013 Feb [cíted 2014 Jun 25];21(1): 127-36. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23369595spa
dc.relation.referencesForton F, Germaux M-A, Brasseur T, De Liever A, Laporte M, Mathys C, et al. Demodicosis and rosacea: epidemiology and significance in daily dermatologic practice. J Am Acad Dermatol [Internet], 2005 Jan [cíted 2014 Jun 25];52(1 ):74—87. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15627084spa
dc.relation.referencesForton F, Seys B. Density of Demodex follículorum in rosacea: a casecontrol study using standardized skin-surface biopsy. Br J Dermatol. 1993;128:650-9.spa
dc.relation.referencesMargot Whitfeld, FACD, MBBSemail, Nishmi Gunasingam, MBBS, Liang Joo Leow, MBBS, Kyoko Shirato, MBBS, Verónica Preda MBs (Hons). Staphylococcus epidermidis: A possible role in the pustules of rosacea. J Am Acad Dermatol. 2011;64(1):49-52.spa
dc.relation.referencesMark V Dahl, MD, Amy J Ross, BS, Patrick M Schlievert P. Temperature regulates bacterial protein production: possible role in rosacea. J Am Acad Dermatol. 2004;50(2):266-72.spa
dc.relation.referencesAbram K, Silm H, Maaroos H-l, Oona M. Risk factors associated with rosacea. J Eur Acad Dermatol Venereol. 2010;24:565-71.spa
dc.relation.referencesJean L Bolognia. Jorizzo, Joseph. Schaffer J. Dermatology. 3rd Editio. Elsevier; 2012.spa
dc.relation.referencesYazici AC, Tamer L, Ikizoglu G, Raya TI, Api H, Yildirim H, et al. GSTM1 and GSTT1 nuil genotypes as possible heritable factors of rosacea. Photodermatol Photoimmunol Photomed. 2006;22:208-10.spa
dc.relation.referencesSopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol [Internet], 2002;2:372-7. Available from: http://dx.doi.Org/10.1038/nr¡803spa
dc.relation.referencesAbraham N, Selby W, Lazarus R, Solomon M. Is smoking an indirect risk factor for the development of ulcerativa colitis? An age- and sex-matched case-control study. J Gastroenterol Hepatol. 2003;18:139-46.spa
dc.relation.referencesSpoendlin J, Voegel JJ, Jick SS, Meier CR. A study on the epidemiology of rosacea in the U.K. Br J Dermatol. 2012;167:598-605.spa
dc.relation.referencesEdvinsson ML, Andersson SE, Xu CB, Edvinsson L. Cigarette smoking leads to reduced relaxant responses of the cutaneous microcirculation. Vasc Health Risk Manag. 2008;4:699-704.spa
dc.relation.referencesMilis CM MR. Environmental factors influencing rosacea. Clin Exp Derm. 1996;21:172-3.spa
dc.relation.referencesTan J, Blume-Peytavi U, Ortonne JP, Wilhelm K, Marticou L, Baltas E, et al. An observational cross-sectional survey of rosacea: Clinical associations and progression between subtypes. Br J Dermatol. 2013;169:555-62.spa
dc.relation.referencesGomaa AHA, Yaar M, Eyada MMK, Bhawan J. Lymphangiogenesis and angiogenesis in non-phymatous rosacea. J Cutan Pathol. 2Ó07;34:748- 53.spa
dc.relation.referencesSchwab VD, Sulk M, Seeliger S, Nowak P, Aubert J, Mess C, et al. Neurovascular and Neuroimmune Aspects in the Pathophysiology of Rosacea. Journal of Investigative Dermatology Symposium Proceedings. 2011. p. 53-62.spa
dc.relation.referencesHuggenberger R, Detmar M. The Cutaneous Vascular System in Chronic Skin Inflammation. Journal of Investigative Dermatology Symposium Proceedings. 2011. p. 24-32.spa
dc.relation.referencesJones D. Reactive oxygen species and rosacea. Cutis [Internet], 2004;74:17-20,32-4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15499754spa
dc.relation.referencesMeyer M, Müller A-K, Yang J, Sulcová J, Werner S. The role of chronic inflammation in cutaneous fibrosis: fibroblast growth factor receptor deficiency in keratinocytes as an example. J Investig Dermatol Symp Proc [Internet], 2011;15:48-52. Available from: http://www.ncbi. nlm.nih.gov/pubmed/22076327spa
dc.relation.referencesPu LL, Smith PD, Payne WG, Kuhn MA, Wang X, Ko F, et al. Overexpression of transforming growth factor beta-2 and its receptor in rhinophyma: an alternative mechanism of pathobiology. Ann Plast Surg. 2000;45:515-9.spa
dc.relation.referencesCrawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol [Internet], 2004 Oct [cited 2014 May 31];51(3):327-41; quiz 342-4. Available from: http://www. nebí. ni m. nih. gov/pubmed/15337973spa
dc.relation.referencesRosso JQ Del, Thiboutot D, Gallo R, Webster G, Tanghetti E, Eichenfield L, et al. Consensus Recommendations From the American Acné & Rosacea Society on the Management of Rosacea, Part 1: A Status Report on the Disease State, General Measures, and Adjunctive Skin Care. Cutis. 2013;Nov(92(5)):234-40.spa
dc.relation.referencesGoldgar C, Keahey DJ, Houchins J. Treatment options for acné rosacea. American Family Physician. 2009.spa
dc.relation.referencesRosso JQ Del, Thiboutot D, Gallo R, Webster G, Tanghetti E, Eichenfield L, et al. Consensus Recommendations From the American Acné & Rosacea Society on the Management of Rosacea, Part 2: A Status Report on Topical Agents. Cutis. 2013;Dec(92(6)):277-84.spa
dc.relation.referencesDel Rosso JQ. Management of facial erythema of rosacea: What is the role of topical ??-adrenergic receptor agonist therapy? J Am Acad Dermatol. 2013;69.spa
dc.relation.referencesLayton A, Thiboutot D. Emerging therapies in rosacea. J Am Acad Dermatol [Internet], Elsevier Inc; 2013 Dec [cited 2014 Jun 5];69(6 Suppl 1):S57-65. Avaílable from: http://www.ncbi.nlm.nih.gov/pubmed/24229638spa
dc.relation.referencesTanghetti E, Rosso JQ Del, Thiboutot D, Gallo R, Webster G, Eichenfield LF, et al. Consensus Recommendations From the American Acné & Rosacea Society on the Management of Rosacea, Part 4: A Status Report on Physical Modalities and Devices. Cutis. 2014;Feb(93(2)):71-6.spa
dc.relation.referencesRosso JQ Del, Thiboutot D, Gallo R, Webster G, Tanghetti E, Eichenfield LF, et al. Consensus Recommendations From the American Acné & Rosacea Society on the Management of Rosacea, Part 3: A Status Report on Systemic Therapies. Cutis. 2014;Jan(93(1)):18-28.spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*
dc.rights.localAbierto (Texto Completo)spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.subject.keywordsDermatologyspa
dc.subject.keywordsMedical sciencesspa
dc.subject.keywordsHealth sciencesspa
dc.subject.keywordsRosaceaspa
dc.subject.keywordsChronic inflammatory diseasespa
dc.subject.keywordsSkinspa
dc.subject.keywordsFace (Diseases)spa
dc.subject.keywordsEpidemiologyspa
dc.subject.keywordsSkin diseasesspa
dc.subject.keywordsCutaneous manifestations of general diseasesspa
dc.subject.lembDermatologíaspa
dc.subject.lembCiencias médicasspa
dc.subject.lembMedicinaspa
dc.subject.lembCara (Enfermedades)spa
dc.subject.lembEpidemiologíaspa
dc.subject.lembEnfermedades de la pielspa
dc.subject.lembManifestaciones cutáneas de enfermedades generalesspa
dc.subject.proposalCiencias de la saludspa
dc.subject.proposalRosáceaspa
dc.subject.proposalEnfermedad inflamatoria crónicaspa
dc.subject.proposalPielspa
dc.titleRosácea: factores asociados y presentación clínica en una población santandereanaspa
dc.title.translatedRosacea: associated factors and clinical presentation in a population of Santanderspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdcc
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.type.driverinfo:eu-repo/semantics/masterThesis
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.type.localTesisspa
dc.type.redcolhttp://purl.org/redcol/resource_type/TM

Archivos

Bloque original

Mostrando 1 - 1 de 1
Miniatura
Nombre:
2015_Tesis_Ramirez_Blanco_Natalia_Milena.pdf
Tamaño:
27.81 MB
Formato:
Adobe Portable Document Format
Descripción:
Tesis
Descargar

Bloque de licencias

Mostrando 1 - 1 de 1
Miniatura
Nombre:
license.txt
Tamaño:
829 B
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Especialización en Dermatología